UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000050762
Receipt number R000057846
Scientific Title Exploratory study for evaluation index of dietary balance in biological samples by metabolome analysis
Date of disclosure of the study information 2023/04/04
Last modified on 2023/10/03 09:47:09

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Exploratory study for evaluation index of dietary balance in biological samples by metabolome analysis

Acronym

Exploratory study for evaluation index of dietary balance in biological samples by metabolome analysis

Scientific Title

Exploratory study for evaluation index of dietary balance in biological samples by metabolome analysis

Scientific Title:Acronym

Exploratory study for evaluation index of dietary balance in biological samples by metabolome analysis

Region

Japan


Condition

Condition

Healthy Adults

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

A comprehensive search for indicators in biological samples that reflect the dietary balance consumed by adults between 20 and 50 years of age.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Dietary content for 3 days and metabolite levels and ratios in urine and blood by metabolome analysis.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

50 years-old >

Gender

Male and Female

Key inclusion criteria

1.Persons who received a sufficient explanation of the purpose and contents of the exam, have the capacity to consent, applied with free will with sufficient understanding, and agreed to participate with a written document
2.Healthy Japanese who are 20 years old or more and under 50 years old

Key exclusion criteria

1.Persons who have any chronic illnesses with medication and who have any serious disease histories
2.Persons who regularly use medicines or foods with health claims (foods for specified health use, foods with functional claims and foods with nutritional claims) etc., that may affect Urinary and blood metabolites
3.Persons who were judged as inappropriate for study participant by the principal investigator
4.Persons who are breast-feeding, pregnant and planning or wishing to become pregnant during the study period
5.Persons who are taking antithrombotic or antiplatelet drugs

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Naoko
Middle name
Last name Kimura

Organization

Healthcare Systems Co., Ltd.

Division name

Research and Development Department

Zip code

466-0058

Address

1-14-18 Shirakane, Showa-ku, Nagoya city, Aichi, JAPAN

TEL

052-734-8885

Email

kimura.naoko@hc-sys.jp


Public contact

Name of contact person

1st name Naoko
Middle name
Last name Kimura

Organization

Healthcare Systems Co., Ltd.

Division name

Research and Development Department

Zip code

466-0058

Address

1-14-18 Shirakane, Showa-ku, Nagoya city, Aichi, JAPAN

TEL

052-734-8885

Homepage URL


Email

kimura.naoko@hc-sys.jp


Sponsor or person

Institute

Healthcare Systems Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Healthcare Systems Co., Ltd.

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Human Metabolome Technologies, Inc.

Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Ethics Committee of Healthcare Systems Co., Ltd.

Address

1-14-18 Shirakane, Showa-ku, Nagoya city, Aichi, JAPAN

Tel

052-734-8885

Email

soumu@hc-sys.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 04 Month 04 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

22

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2023 Year 02 Month 15 Day

Date of IRB

2023 Year 02 Month 15 Day

Anticipated trial start date

2023 Year 04 Month 11 Day

Last follow-up date

2023 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

A comprehensive search for indicators in biological samples that reflect the dietary balance consumed.


Management information

Registered date

2023 Year 04 Month 04 Day

Last modified on

2023 Year 10 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000057846


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name